Literature DB >> 26680327

New regulation for clinical stem cell research in China: expected impact and challenges for implementation.

Achim Rosemann1,2, Margaret Sleeboom-Faulkner2,3.   

Abstract

Keywords:  China; clinical translation; international harmonization; life science governance; new regulation; stem cell research

Mesh：

Year:  2015        PMID： 26680327     DOI： 10.2217/rme.15.80

Source DB:  PubMed          Journal:  Regen Med        ISSN： 1746-0751            Impact factor:   3.806


× No keyword cloud information.
  7 in total

1.  Regulated and Unregulated Clinical Trials of Stem Cell Therapies for Stroke.

Authors:  Michael G Liska; Marci G Crowley; Cesar V Borlongan
Journal:  Transl Stroke Res       Date:  2017-01-26       Impact factor: 6.829

2.  Accreditation of Biosafe Clinical-Grade Human Embryonic Stem Cells According to Chinese Regulations.

Authors:  Qi Gu; Juan Wang; Lei Wang; Zheng-Xin Liu; Wan-Wan Zhu; Yuan-Qing Tan; Wei-Fang Han; Jun Wu; Chun-Jing Feng; Jin-Hui Fang; Lei Liu; Liu Wang; Wei Li; Xiao-Yang Zhao; Bao-Yang Hu; Jie Hao; Qi Zhou
Journal:  Stem Cell Reports       Date:  2017-05-11       Impact factor: 7.765

3.  Exploiting science? A systematic analysis of complementary and alternative medicine clinic websites' marketing of stem cell therapies.

Authors:  Blake Murdoch; Amy Zarzeczny; Timothy Caulfield
Journal:  BMJ Open       Date:  2018-02-28       Impact factor: 2.692

Review 4.  Development and regulation of stem cell-based therapies in China.

Authors:  Jianchao Gao; Chenyan Gao
Journal:  Cell Prolif       Date:  2022-04-13       Impact factor: 8.755

5.  Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world.

Authors:  Kazuo Yano; Masayuki Yamato
Journal:  Regen Ther       Date:  2018-04-07       Impact factor: 3.419

6.  Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis.

Authors:  Julia Deinsberger; David Reisinger; Benedikt Weber
Journal:  NPJ Regen Med       Date:  2020-09-11

Review 7.  Stem cell 'therapy' advertisements in China: Infodemic, regulations and recommendations.

Authors:  Jianwei Lv; Yeyang Su; Lingqiao Song; Xia Gong; Yaojin Peng
Journal:  Cell Prolif       Date:  2020-11-04       Impact factor: 6.831
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.